–
Keros Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.4
FY22:
−115
FY23:
−170
FY24:
−211
FY25:
67.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.4
FY22:
–
FY23:
–
FY24:
–
FY25:
44.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.7
FY22:
−105
FY23:
−153
FY24:
−187
FY25:
91.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.7
FY22:
−105
FY23:
−153
FY24:
−187
FY25:
87.0
All amounts in millions USD